Brazil
The company's presence in the Consumer Health market, encompassing over-the-counter medications, supplements, and vitamins, includes iconic brands such as Benegrip, Buscopan, Engov, Epocler, Estomazil, Neosaldina, and Zero-Cal. It also operates in the Prescription Products segment through the Mantecorp Farmasa line and in dermocosmetics with brands like Mantecorp Skincare, Simple Organic, and Bioage. Moreover, it has a strong presence in Generic Medicines and Similars through Neo Química. Recently, the company expanded its participation to the Institutional Market, targeting clinics and hospitals.
Headquartered in São Paulo and listed on the Novo Mercado of BM&FBovespa since 2008, Hypera Pharma boasts a team of over 3,400 employees. Notably, in 2023, the company became a part of the Environmental, Social, and Governance (ESG) Corporate Sustainability Index of the Brazilian stock exchange, recognizing its exemplary ESG practices.
The company operates within the Health and Wellness, Pharmaceutical, and Wellness Beauty industries, reflecting its diverse portfolio and business interests. While there is no specific information available regarding the last investment or investors, Hypera Pharma's strong market position and commitment to sustainability make it an attractive prospect for potential investors seeking exposure to the pharmaceutical and healthcare sectors.
